During 2021-2025 endovenous ablation devices market size will grow by $ 156.60 almost at a CAGR of almost 6%.
North America will provide significant growth opportunities to vendors. During the forecast period the region will account for 45% of the market’s growth.
Market Overview
Get sample illustrations from Technavio’s research report on the endovenous ablation devices market
Growth in the market will be driven by factors such as the Increasing prevalence of CVI. The Increasing popularity of performing endovenous procedures in an outpatient setting will also have a significant influence on the growth of the endovenous ablation devices market during the forecast period.
Though the market will offer several growth opportunities, factors such as High cost coupled with unfavorable reimbursement policies will also challenge the growth of the market participants.
AngioDynamics Inc., AtriCure Inc., Eufoton srl, and Johnson & Johnson are some of the key endovenous ablation devices market vendors.
The report provides an analysis of the market’s competitive landscape, the strategies adopted by companies to increase their market share, and the key products or services they provide. The report also analyzes the market based on segmentations such as Product (EVLT devices, RFA devices, and NTNT devices) and Geography (North America, Europe, Asia, and ROW). To improve their market positions, the vendors should focus more on the fast-growing segments.
Market Analysis Insights 